T. Gooley

Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older

F. Appelbaum, W. Bensinger, S. Petersdorf, 2001, Bone Marrow Transplantation.

A randomized study of melphalan 200 mg/m2 vs 280 mg/m2 as a preparative regimen for patients with multiple myeloma undergoing auto-SCT

D. Maloney, T. Gooley, O. Press, 2016, Bone Marrow Transplantation.

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

D. Maloney, T. Gooley, O. Press, 2006, Bone Marrow Transplantation.

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas

I. Bernstein, J. Eary, W. Nelp, 1995, The Lancet.

A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma

N. Burwick, P. Becker, W. Bensinger, 2016, Blood Cancer Journal.

Trafficking of CD34+ cells into the peripheral circulation during collection of peripheral blood stem cells by apheresis

S. Heimfeld, D. Maloney, T. Gooley, 2001, Bone Marrow Transplantation.

Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemia.

M. Boeckh, T. Gooley, R. Bowden, 1998, The Journal of infectious diseases.

Conditioning Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Kinetics of Engraftment in Patients with Hematological Malignancies Given

J. Radich, S. Heimfeld, R. Storb, 2009 .